AstraZeneca
AZN
AZN
945 hedge funds and large institutions have $29.4B invested in AstraZeneca in 2021 Q4 according to their latest regulatory filings, with 149 funds opening new positions, 267 increasing their positions, 326 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $31.1B → $29.4B (-$1.7B)
18% less repeat investments, than reductions
Existing positions increased: 267 | Existing positions reduced: 326
24% less funds holding in top 10
Funds holding in top 10: 17 → 13 (-4)
Holders
945
Holding in Top 10
13
Calls
$713M
Puts
$509M
Top Buyers
| 1 | +$438M | |
| 2 | +$149M | |
| 3 | +$107M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$91.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$84.8M |
Top Sellers
| 1 | -$352M | |
| 2 | -$305M | |
| 3 | -$148M | |
| 4 |
BlackRock
New York
|
-$127M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$120M |